This is a double-blind, randomized controlled trial comparing WBV therapy with a placebo intervention and standard care. A total of 150 participants will be recruited and investigated from Prince Mutib Hospital. Participants will be randomly allocated to one of three groups: WBV therapy, placebo (non-vibrating platform), or control (standard care). The study duration will be 12 weeks, with assessments conducted at baseline, post-intervention (12 weeks), and at a 6-month follow-up.
Protocol Parameters Summary
* Session Frequency: 3 times per week.
* Session Duration: 25 minutes per session.
* Vibration Frequency: 30 Hz.
* Amplitude: 1-2 mm.
* Program Duration: 12 weeks.